Medicines Health Products Particular products Medicines Homeopathic medicines Herbal medicinal products Biological and biosimilar medicinal products Generic medicinal products Medical devices and their accessories Human body material Blood and blood products Raw materials Specially reglemented substances Grey area
13/11/2023 PRAC November 2023 – Conclusion regarding available evidence not supporting link between the glucagon-like peptide-1 (GLP-1) receptor agonists and thyroid cancer
26/10/2023 Limited availability of GLP-1 analogues: recommendations for medical doctors (specialists), (hospital) pharmacists and patients